These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 986241)
81. Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. McNamee EN; Korns Johnson D; Homann D; Clambey ET Immunol Res; 2013 Mar; 55(1-3):58-70. PubMed ID: 22961658 [TBL] [Abstract][Full Text] [Related]
82. Bnip3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis. Qi Y; Tian X; Liu J; Han Y; Graham AM; Simon MC; Penninger JM; Carmeliet P; Li S J Cell Biol; 2012 Jul; 198(1):103-14. PubMed ID: 22753893 [TBL] [Abstract][Full Text] [Related]
83. Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [(18)F]EF5. Eskola O; Grönroos TJ; Forsback S; Tuomela J; Komar G; Bergman J; Härkönen P; Haaparanta M; Minn H; Solin O Mol Imaging Biol; 2012 Apr; 14(2):205-12. PubMed ID: 21448777 [TBL] [Abstract][Full Text] [Related]
84. Evaluation of hypoxic tissue dynamics with 18F-FMISO PET in a rat model of permanent cerebral ischemia. Rojas S; Herance JR; Abad S; Jiménez X; Pareto D; Ruiz A; Torrent È; Figueiras FP; Popota F; Fernández-Soriano FJ; Planas AM; Gispert JD Mol Imaging Biol; 2011 Jun; 13(3):558-564. PubMed ID: 20602176 [TBL] [Abstract][Full Text] [Related]
86. Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Glunde K; Artemov D; Penet MF; Jacobs MA; Bhujwalla ZM Chem Rev; 2010 May; 110(5):3043-59. PubMed ID: 20384323 [No Abstract] [Full Text] [Related]
87. New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting. Lee NY; Le QT Semin Oncol; 2008 Jun; 35(3):236-50. PubMed ID: 18544439 [TBL] [Abstract][Full Text] [Related]
88. Clinical biomarkers for hypoxia targeting. Le QT; Courter D Cancer Metastasis Rev; 2008 Sep; 27(3):351-62. PubMed ID: 18483785 [TBL] [Abstract][Full Text] [Related]
89. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675 [TBL] [Abstract][Full Text] [Related]
90. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. Raleigh JA; La Dine JK; Cline JM; Thrall DE Br J Cancer; 1994 Jan; 69(1):66-71. PubMed ID: 8286212 [TBL] [Abstract][Full Text] [Related]
91. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Koch CJ; Evans SM; Lord EM Br J Cancer; 1995 Oct; 72(4):869-74. PubMed ID: 7547233 [TBL] [Abstract][Full Text] [Related]
92. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro. Taylor YC; Rauth AM Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314 [TBL] [Abstract][Full Text] [Related]
93. Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice. Conroy PJ; Von Burg R; Penney DP; Passalacqua W; Sutherland RM Br J Cancer; 1980 Apr; 41(4):523-8. PubMed ID: 7387850 [TBL] [Abstract][Full Text] [Related]
94. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro. Stratford IJ; Williamson C; Hardy C Br J Cancer; 1981 Jul; 44(1):109-16. PubMed ID: 7259957 [TBL] [Abstract][Full Text] [Related]